- Doctors studying cohorts of cancer patients who were infected with the novel coronavirus made a startling discovery.
- Men with prostate cancer who were under androgen-deprivation therapy were less likely to get COVID-19, and less likely to develop a severe case if they were infected.
- The researchers think ADT therapy may protect men from the novel coronavirus.
- Visit BGR’s homepage for more stories.
With each day that goes by, we keep hearing of novel coronavirus therapies that can speed up recovery time and potentially reduce the risk of complications and death. It seems like doctors are throwing everything at the disease to see what sticks, but that’s not exactly the case. They’ve simply had time to observe that some of the drugs that were created for other ailments can help COVID-19 patients as well. One such example is remdesivir, which was developed for Ebola but never used to treat it. Then there’s the controversial hydroxychloroquine, a decades-old anti-malarial that can help some COVID-19 patients, but it’s not as effective and safe as people would have hoped. Anti-viral favipiravir (Avigan) was made for influenza but it might work on COVID-19 as well. And if this new study is right, a treatment that’s usually given to prostate cancer patients could be used to protect men from the novel coronavirus.
Today’s Top Deals
- Here are this week’s 5 best-selling electronics devices on Amazon
- Today’s best deals: Best-selling face masks and hand sanitizer, $22 earphones, $100 off Bose 700, Amazon devices, more
- Everyone’s swarming Amazon for these coronavirus face masks
Trending Right Now:
- A leaker might’ve just revealed Sony’s exact PS5 design reveal date
- Scientists have developed antibodies that can kill coronavirus
- A man let a murder hornet sting him on purpose and the video is insane
This startling discovery might protect men from coronavirus originally appeared on BGR.com on Fri, 8 May 2020 at 14:09:26 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report